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Tubular basement membrane changes during induction and regression
of drug-induced polycystic kidney disease. Defective cell-extracellular
matrix (ECM) biophysiology is considered a factor in the development of
polycystic kidney disease (P1(D). Altered biosynthesis of various ECM
components may result in tubular dysmorphogenesis and uncontrolled
tubular cystic expansion. In this study, expression of certain ECM com-
ponents was investigated in a diphenylthiazole (DPT)-induced rat model
of PKD. DPT induces cystic change in all the collecting tubules, most
severe in the outer medulla and inner cortex, and following withdrawal of
DPT, cystic tubules return to normal with persistence of focal interstitial
fibrosis. SDS-PAGE analyses of isolated tubular basement membranes
(TBMs) of control and PKD kidneys revealed overall similar electro-
phoretic migratory bands. However, in PKD, there were relative increases
in components with Mr 380,000, 250,000 and 145,000, and a decrease in
the component with Mr 55,000. Immunoblot analyses revealed that the
major components of TBM (type-IV collagen, laminin I3 and 132 chains
and entactin) were present in the same relative concentrations in control
and PKD. The expression of tubulointerstitial (TIN) antigen was de-
creased. Also, the relative concentrations of type-I collagen and fibronec-
tin were increased in the PKD group. Following recovery, the expressions
of TIN and fibronectin returned to normal, whereas type-I collagen
remained elevated. ELISA determinations revealed increased expression
of interstitial collagens type-I, -V and -VI in PKD vs control and they
remained elevated following recovery, while that of type-Ill was un-
changed. Since cell-matrix integrity is vital in the maintenance of normal
biophysiology of the renal tubule, the observed altered expressions in
various ECM glycoproteins may be relevant to the pathogenetic mecha-
nisms involved in the development and progression of PKD.
In polycystic kidney disease (PKD), lumina of multiple tubular
segments and Bowman's capsule of the glomeruli expand progres-
sively, impinge upon the normal renal parenchyma and cause a
certain degree of renal functional impairment [1, 2]. Various
biosynthetic processes, cell and extracellular matrix (ECM) inter-
actions and regional specialized transport mechanisms maintain
normal tubular morphology [3, 4]. In PKD, tubular dysmorpho-
genesis occurs resulting in uncontrolled tubular dilatation due to
a defect in cell-ECM homeostasis. In both human and experimen-
tal forms of PKD, certain biochemical and structural changes of
ECM have been delineated in vivo and in vitro [5—10]. The tubular
basement membranes (TBM) lining cysts are greatly thickened,
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and have decreased synthesis and expression of proteoglycans
(PG), and altered immunoreactivities for other ECM glycopro-
teins, for example, fibronectin (FN) and type-I collagen have been
noted in human forms of PKD. In a previous study [6], biochem-
ical changes in non-collagenous polypeptides in TBMs of kidneys
with diphenylthiazole (DPT)-induced PKD were observed, and
these alterations regressed with the discontinuation of DPT.
Besides the changes in various matrix components, impaired
intracellular synthesis and processing of sulfated glycoproteins
(SGPs) in the Golgi complex was observed [11]. The PGs so
synthesized were undersulfated, and conceivably, this led to their
defective interactions with other ECM and thickening of the
TBMs. Collectively, these observations indicate that the alter-
ations in the TBM glycoproteins are relevant to the pathogenesis
of PKD.
In addition to the changes in the integral components of the
TBMs, PKD is also accompanied with tubulointerstitial alter-
ations involving the non-cystic tubules, contributing further to the
loss of renal functions. In PKD-induced chronically in rats by the
dietary administration of DPT, tubules underwent atrophy and
compensatory hypertrophy, along with interstitial fibrosis and
expansion, leading to an additional compromize in the renal
functions [2]. In this study, alterations in the biochemical charac-
teristics of certain integral components of the TBMs and of the
TBM-associated interstitial glycoproteins were investigated in the
DPT-induced PKD in rats.
Methods
Disease in4uction
Rats were fed a diet containing 1.06% DPT to induce PKD.
Three groups of 25 rats each were studied: (I.) PKD group of rats
were fed DPT for eight weeks; (II.) control group was pair-fed
with the normal diet for eight weeks; and (III.) recovery group of
rats were fed DPT for eight weeks followed by the normal diet for
eight weeks. At the time of sacrifice, kidneys from five rats in each
group were fixed in phosphate-buffered formalin, processed and
stained with hematoxylin and eosin for light microscopy. Kidneys
from the remaining 20 rats in each group were then quick frozen
in dry ice.
Preparation of tubular basement membranes
TBMs were prepared as described previously [6]. Cortex and
outer medulla were dissected from frozen kidneys and placed in
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0.05 M Tris, 0.15 M NaC1, pH 7.5, containing protease inhibitors
N-ethylmaleimide, ethylenediaminetetraacetic acid, €-aminocap-
roic acid, each at a concentration of 1 m, and 2 m'vi diisopropyl
fluorophosphate which was added to the solution immediately
before use. Isolation of TBMs was performed using 20 kidneys
each from control and DPT-treated animals at 4°C. The dissected
cortices, from five kidneys at a time, were pressed through a #60
stainless steel sieve. The residue from the top and the paste from
the bottom of the screen were collected using a razor blade, and
placed in a 400 ml beaker containing 250 ml of protease inhibitor
solution. The tissues were disrupted with a Brinkman Polytron
tissue homogenizer, equipped with 1 cm probe, at 40% of
maximum power for 30 seconds. The homogenate was then
poured through the #60 sieve. Tissue fragments filtered through
the #60 sieve were collected on the top of #100 mesh sieve, and
re-subjected to another brief Polytron treatment in order to
dislodge glomeruli adherent to the tubules. The final tissue
product was collected on the top of #100 mesh sieve and
concentrated by centrifugation at 5000 x g in a 40 ml polypro-
pylene tube. Pellets were dispersed in 30 ml of 1 M NaCl solution
containing the protease inhibitors by using the Polytron at mini-
mum power for 15 seconds. The suspension was subjected to
sonication for two minutes in 20 second bursts using a Heat
Systems Biosonic 375 sonicator with a 1 cm probe. The sonicated
TBMs were passed over a #200 mesh sieve to remove undisrupted
material, and the filtered material was collected and centrifuged
at 2000 X g. The TBM pellets were washed in 1 M NaCI-protease
inhibitor solution, followed by twice in distilled water and lyo-
phized.
Antibodies
Goat polyclonal antibodies to type-I, -III, -v and -VI collagens
were obtained from Southern Biotechnology (Farmingham, Ala-
bama, USA). The characteristics of rabbit polyclonal anti-type-IV
collagen (anti-Mi) have been described previously [12, 13].
Monoclonal anti-type-IV collagen triple helical domain (H3F7)
was from the Hybridoma Bank (Johns Hopkins University, Mary-
land, USA) [14]. Polyclonal anti-laminin was a gift from Dr. Aris
Charonis (University of Minnesota, Minneapolis, Minnesota,
USA), and monoclonal anti-laminin (2E8) was from the Hybrid-
oma Bank. Affinity purified anti-entactin and monoclonal, A9, to
entactin have been previously characterized [15]. Preliminary
studies were carried out with anti-entactin, kindly provided by Dr.
Albert Chung [16]. Polyclonal anti-fibronectin was purchased
from Southern Biotechnology. Human autoantibodies (TIN-i) to
tubulointerstitial nephritis (TIN) antigen were a gift from Dr.
Giuseppe Andres (Columbia University, New York, USA) [17].
Monoclonal anti-TIN antigen (A8) was used to confirm the results
obtained with the human antibody. Specificity of the autoantibod-
ies and monoclonal antibodies to TIN antigen have been previ-
ously reported [17—19].
Immunochemical studies
Protein content of TBM preparations was determined by a
modified Lowry's method [20]. SDS-PAGE, using 5% to 18%
linear gradient gels in discontinuous buffers, was performed
according to Laemmli's procedure [21]. The TBMs were sus-
pended in Laemmli's SDS-PAGE sample buffer at 1.0 mg/mI and
dispersed with a Polytron tissue disruptor at 30% maximum power
for 15 seconds. When reduction of disuffide bonds was required,
4.0% p-mercaptoethanol was added to the sample prior to heat
treatment. Prior to application to the gels, the sample was heated
at 90°C for three minutes followed by centrifugation at 10,000 x
g for five minutes. For immunoblot analyses, samples of TBM
from PKD and control rat kidneys were applied to gels in multiple
concentrations ranging from 5 to 40 jig. IgG was included in the
electrophoretic runs as the internal controls to validate the
quantitation of video densitometric tracing of the immunoblots.
Mouse IgG was used for blots to be treated with mouse mono-
clonal primary antibodies, and rabbit IgG when the blot was
immersed in the solution containing polyclonal antibodies. Fol-
lowing electrophoresis, proteins were transferred from gels to
polyivinylidene difluoride (PDVF) transfer membranes (BlO-
RAD Lab., Richmond, California, USA) by semi-dry electroelu-
tion. Migratory band of various proteins were detected by incu-
bating the PDVF membranes in the respective antisera, followed
by incubation with anti-IgG conjugated with alkaline phosphatase,
and then with the appropriate substrate (BlO-RAD Lab). Stained
blots revealed bands corresponding to components reactive with
primary antibodies; bands in the IgG containing lanes corre-
sponded to the immune reactions with secondary antibody only.
Apparent molecular weight determinations were based on
protein standards (BlO-RAD Lab) electrophoresed in the pres-
ence of f3-mercaptoethanol. The following protein standards were
employed: carbonic anhydrase, 29 kD; egg albumin, 45 kD; bovine
plasma albumin, 66 kD; phosphorylase-B, 97 kD; 13-galactosidase,
116 kD and myosin, 205 kD.
Relative concentrations of TBM components were evaluated
from videoscans of immunoblots and by ELISA. A Dage-MTI
SIT-66 camera was used to transmit images to an image processor
linked to a MacIntosh lixc computer system for data storage. The
area of the blot containing the electrophoretic band of interest
was outlined. The software supplied with the image processor
divided the area into equal fractions and determined grey level
scale of each fractional area. The background grey level was
subtracted, and the resulting values were added to compute the
total band intensity.
ELISA
Samples for ELISA determinations were prepared as follows:
collagenous proteins were dissolved by digesting TBM with pep-
sin. Porcine stomach mucosal pepsin (Sigma Chemical Co., St.
Louis, Missouri, USA, 3200 U/mg) was dissolved in 0.5 M acetic
acid to a concentration of 1 mg/mI. The enzyme was added to rat
TBM (2 mg/ml in 0.5 N acetic acid) at an enzyme/substrate (E/S)
protein ratio of 10% (wt/wt) and incubated with overnight at 4°C
with constant stirring. Collagenous proteins were precipitated in
2.5 M NaCl by addition of an equal volume of cold, 5 M NaC1.
Following centrifugation at 10,000 X g for 30 minutes, they were
re-dissolved in 0.1 M acetic acid and lyophilized. Non-collagenous
proteins were extracted from the TBMs by incubating overnight in
6 M guanidine-HC1, 0.05 M Tris, pH 7.5 at 37°C. Aliquots of the
extracts and pepsin digests were precipitated at 4°C with a tenfold
excess of ethanol, and analyzed for protein content. ELISA was
performed using samples coated onto polystyrene microtiter wells
in 6 M guanidine-HC1, 0.05 M Tris, pH 7.4. Microtiter plates were
incubated overnight at room temperature, then washed and
incubated with antisera diluted in 0.15 M NaCl, 0.05% Tween-20,
.
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Fig. 1. Outer medulla and inner renal corta of control (panel 1), DFT-treated for 8 weeks (panel 2) and 8 weeks of recovety (panel 3). OPT induced cystic
change in collecting tubules (panel 2). Cystic changes regressed completely following withdrawal of DPT (panel 3) but foci of interstitial fibrosis
remained (arrows) (magnification X 100).
0.2% bovine serum albumin. Plates were then washed and incu-
bated with alkaline phosphatase conjugated with secondary anti-
body. The enzyme activity was determined by using ir-nitrophenyl
phosphate substrate. The colorometric EIS reaction was read at
an absorbance of 414 nm.
Results
Light microscopy
Compared to controls, rats receiving DPT for eight weeks
developed notable cystic change in all collecting tubules, mostly
confined in the outer medulla and inner cortex (Fig. 1). In rats
receiving DPT for eight weeks followed by eight weeks of normal
diet, the cystic changes in the collecting tubules regressed and the
tubules appeared normal; however, fibrosis with focal expansion
of the interstitium in the outer medulla and inner cortex was
frequently observed (Fig. 1).
Tubular basement membrane
Weight of PKD kidneys and yield of TBM were both nearly
threefold higher from PKD kidneys than from the controls (Table
1). The yield of TBM in these experiments was higher than
previously reported, which may be related to the improvements
made in the tissue disruption techniques [6]. SDS-PAGE analysis
(Fig. 2, panel pair 1) revealed the electrophoretic migratory bands
as previously described [6]. In general, the bands in PKD and
control TBM were similar; however, relative intensities of several
bands were different in PKD as compared to the control. Relative
increase in the components with Mr 380,000, 250,000 and
145,000 was observed, while with the Mr -55,000 component was
decreased. Based upon the staining intensity, the band with M -
Table 1. Rat TBMs in DPT-induced polycystic kidney disease
Yield?
mg/kidney
thy weight
average kidney weight
g mg/g kidney
Control 1.5 0.7 0.1 2.1
Polycystic 4.9 2.0 0.3 2.54
a Based upon experiments using 20 rats
55,000 was one of the major component, whereas the other bands
seemed to be minor components of the TBM preparations. Other
major components having apparent molecular weights compara-
ble with that of laminin p-chain, entactin and type-IV collagen
appeared to be present in the same relative concentrations in
PKD and control TBM (Fig. 2, panel pair 1).
Identification of TBM components
Immunoblot analyses were carried out to delineate the differ-
ences in various specific glycoproteins between the two groups.
The major structural components of TBM including type-IV
collagen, laminin l1 and j32 chains, and entactin appeared to be
present in the same relative concentrations in PKD and control
TBMs (Fig. 2, panel pairs 2, 3 and 4).
The Mr - 55,000 component was decreased, and it was
identified as TIN antigen by immunoblot analysis (Fig. 2, panel
pair 5). The example in Figure 2 shows undetectable amount of
TIN antigen in the TBM of the PKD group; however, ELISA and
videoscan measurements indicated 70 to 80% reduction of this
component (described below). The components with elevated
concentration in PKD TBM were identified as type-I collagen and
205 —
116 —.
67 —s.
45 —s.
I 2 3 4 5 6
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Fig. 2. Comparison of TBMs from Control and PKD rats by SDS-PAGE and immunoblot analyses. Silver stained gels (panel pair 1) reveal overall
similarity in the electrophoretic bands of control (left lane) and PKD TBM (right lane); however, relative staining intensity of some bands are different
(asterisks), Immunoblot analysis identified components whose relative concentrations were similar (panel pairs 2, 3 and 4), and those whose
concentrations differ (panel pair 5, 6 and 7) between control and PKD TBMs. Examination of the major basement membrane components, type-IV
collagen a1(IV) and a2(IV) chains (panel pair 2), laminin J2 chain (panel pair 3) and entactin (panel pair 4) reveal similar staining intensities between
control and PKD TBMs, suggesting these components were synthesized in approximately equivalent amounts in PKD as in control rats. Analysis of TIN
antigen reveals that it is reduced in PKD TBMs (panel pair 5, right lane). Fibronectin (panel pair 6) and type-I collagen (panel pair 7) which are found
in renal interstitium, are increased in concentrations in TBMs prepared from PKD kidneys, suggesting their synthesis is increased in the disease process.
Arrows and numbers indicate mobilities of standard marker proteins relative to the silver stained gel (panel pair 1). Immunoblots (panel pairs 2 to 7)
were aligned so that bands appear at the appropriate molecular weights with respect to the standards.
fibronectin (Fig. 2, panel pairs 6 and 7). The type-I collagen
corresponds to the Mr - 145,000 component, as determined by
globular protein standards. Its molecular weight determined with
collagenous standards is - 100 kD. The intact fibronectin with
disulfide bonds corresponds to the Mr 350,000 component; and
to the Mr - 250,000 component after reduction. In rats receiving
DPT for eight weeks followed by eight weeks of normal diet, both
TIN antigen and fibronectin reverted back to normal concentra-
tions, whereas the expression of type-I collagen remained elevated
(figure not included).
To support these qualitative observations on the relative con-
centrations of TBM components in PKD, experiments were
performed to quantii' relative amounts of selected TBM compo-
nents. Several approaches were explored for quantification of
TBM components, including inhibition ELISA, direct ELISA and
video densitometry of immunoblots. ELISA determinations were
considered to be the least accurate due to the insolubility of TBM
components in neutral buffers and lack of precision of direct
ELISA for detecting small differences between PKD and control
TBMs. On the other hand, quantification of intensity of electro-
phoretic bands on immunoblots by video densitometry should
provide accurate measurements since SDS solubilized nearly all
the non-collagenous proteins as well as a small amounts of the
collgenous proteins, and addition of reducing agents result in
almost complete solubilization of the TBMs [6].
Parallel samples representing 5 p.g, 10 g, 20 p.g and 40 g of
PKD and control TBMs were applied to the electrophoresis gel
and processed for detection of specific glycoproteins. Scans of the
resulting immunoblots provided measurements of peak areas. A
linear relationship existed between peak area intensity and quan-
tity of soluble TBM applied to the gel, indicating analytical concen-
tration was the single variable, and thus established the validity of
this method. The linear relationship between the migratory band
intensity and the quantity of protein applied to the electrophoresis
gel was also demonstrated with purified IgG in the range of 1 to
25 (figure not included).
Figure 3 presents a densitometric analytical scan comparing
reduced fibronectin from PKD and control TBM. An average of
fourfold increase in the fibronectin from PKD rats was detected
by the image processor (Table 2). A similar fourfold increase in
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Fig. 3. Quantification of immunoblots of fibronectin in control (A) and
PKD (B) TBM by densitomer scanning. An immunoblot of fibronectin was
prepared as described in Figure 2, and scanned to measure the area under
the reaction band. For illustration, immunoblots were placed horizontally
along the thin line in panels A and B. The bands in the immunoblot just
above the lines indicate the positive reaction for fibronectin. The thick
horizontal line represents the 2 cm region of the immunoblot that was
scanned. The lower portion of panels A and B represent the scan tracing
where tick marks indicate increments of distance for grey scale intensity
determinations. Twenty micrograms of TBMs in SDS buffer containing
2% 3-mercaptoethanol were applied to the gels.
Table 2. Relative abundance of components in TBM from PKD and
control kidneys
Matrix component
Relative quantity"
(PKD/control)
TIN antigen 0.3 0.1
Fibronectin 4.0 0.3
Laminin 0.9 0.1
Entactin 1.1 0.2
Type IV collagen
Globular domain 1.1 0.2
Triple helical domaio 1.3 0.1
Type I collagen 4.1 0.2
"Determined from scans of immunoblots; measurements were made at
3 different protein concentrations
type-I collagen was elucidated by this method (Table 2). By
contrast, TIN antigen decreased to about 30% of its control values
in the PKD group. The intrinsic basement membrane compo-
nents, laminin, entactin and type-IV collagen did not differ
significantly in concentrations in PKD versus control TBM, sup-
porting the conclusions of the observations made by visual
examinations of the immunoblots.
The finding of similar relative concentrations of intrinsic base-
ment membrane components in PKD and control TBM suggests
that the basement membrane may be increased in mass but
unaltered in its overall biochemical composition. The presence of
increased fibronectin and type-I collagen suggests certain
amounts of interstitial components in PKD may be carried along
with TBM during its purification. To further explore this possibil-
Dilution
Fig. 4. ELISA analysis of type- VI collagen in TBM from control and DPT
treated rats. Pepsin soluble TBM collagen was dissolved at a concentration
of 1 mg/mI in 6 M guanidine HCI and 50mM Tris buffer, pH 7.4, and coated
onto microtiter plates in dilutions ranging from 1 to 20 made in the same
buffer. Sample dilution as a function of color development is shown for
control (0 - 0), PKD (U - U) and PKD following an eight week recovery
period (A - A). Dilutions reqoired to give equivalent color development
for control and PKD samples at various points along the curve indicate>
threefold relative quantities of type-VI collagen are present in PKD
samples, Preparations of TBM following an S week recovery period where
administration of DPT was discontinued, have the same relative amounts
of type-VI collagen as the PKD samples.
Table 3. Relative abundance of various types of collagens associated
with 'FBM in KJ)
Collagen type
Relative quantity
(PKD/control)
I >3
III 1.1
V >3
VI >3
ity, ELISA was performed to determine relative amounts of
interstitial collagens type-I, -III, -V and -VI. The collagen types-I,
-V and -VI were found at greater than threefold higher concen-
trations in PKD, even after the recovery period. These results are
illustrated in Figure 4 and in Table 3. Unlike the other interstitial
collagens, type-Ill collagen was not found in elevated concentra-
tions in PKD.
Discussion
A threefold increase in renal mass and in the isolated TBMs in
PKD group probably reflects an accentuated renal growth rather
than the development of tubular cystic change. The changes
similar to those induced by DPT have been elucidated with the
administration of a hydroxylated metabolite of DPT, 2-amino-4-
[hydroxyphenyl]-5 phenyl thiazole (designated Phenol II) to the
rats, which were accompanied with an increase in the renal mass
due to proliferation of cells lining both cystic and normal tubules,
a)
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1.0
1.0
A I
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0.9
0.8
E
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0.4
B I
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"Determined by ELISA on pepsin soluble TBM collagen
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and also of interstitial cells resulting in the enlargement of both
the tubular and interstitial compartments [91. Morphologically,
although there is an apparent increase in TBM lining cysts, the
cystic change comprised only a small proportion of the total
tubular mass so the threefold increase in TBM after DPT
administration is due probably to a significant increase in mass of
the normal, noncystic tubules. The latter would also account for
the major TBM components type-IV collagen, laminin and entac-
tin being present in approximately the same amounts per mass of
TBM in both control and PKD groups.
Matrix (interstitial) changes, as well as tubular cyst formation,
may be primary manifestations of PKD. Both epithelial and
interstitial cells (fibroblasts) may modulate the turnover of inter-
stitial stromal macromolecules. Collagen types-I, -V and -VI and
fibronectin, generally considered components of the renal inter-
stitium, were significantly increased in TBMs isolated from PKD
versus control kidneys. We found that chronic administration of
DPT for up to 30 weeks induced two types of progressive tubular
changes: cyst formation and hyperplastic/atrophic change in non-
cystic tubules, both accompanied by expansion of the interstitium
[2]. Fibroblasts from patients with autosomal dominant PKD in
vitro have an increased proliferative capacity to acidic fibroblastic
growth factor and express increased levels of mRNA for type-I
collagen consistent with increased matrix formation [22]. In
cpklcpk mice with PKD, mRNA expression for collagen type-IV
was localized by in situ hybridization to interstitial cells adjacent to
cysts and not in epithelial cells [23]. In this study, the substantially
increased fibronectin content found in cystic kidneys correlates
with the increased immunohistochemical reactivity noted previ-
ously [7, 9]. In another study, the epithelial cells from ADPKD
kidneys were found to produce increased amounts of collagens
which do not share homologies with the major collagen molecules
[24]. Thus, increased expression and production of interstitial
stromal components by interstitial cells may be a primary response
in PKD which may have an important role in the progression and
renal functional impairment of the disease. TBM and interstitial
changes are largely reversible, since with recovery, following the
induction of PKD by DPT, levels of collagen-I V, laminin, entactin
and fibronectin returned to normal. Levels of collagen type-I,
however, remained elevated and correlated with persistence of
the foci of fibrosis and expansion of the interstitium after eight
weeks of recovery. Whether levels of interstitial collagens and
interstitial fibrosis return to normal with periods of recovery
beyond eight weeks remains to be determined.
Type-I collagen is developmentally expressed in an uninduced
mesenchyme and disappears following induction [3, 25]. A num-
ber of studies indicate a developmental arrest (dedifferentiation)
of cells lining cysts in PKD [26, 27]. Increased expression of type-I
collagen in DPT-induced PKD may be an expression of a devel-
opmental arrest. However, increased expression of type-I collagen
in the kidney may be a general response to injury since it has been
reported in several renal abnormalities including obstructive
nephropathy [28] and puromycin aminonucleoside nephrosis [29].
TIN antigen is a tissue specific component associated with renal
basement membrane, and also found in renal interstitium [30].
Decreased amounts of TIN antigen in DPT-induced PKD may
reflect a developmental arrest resulting in increased growth.
Conceivably, TIN antigen plays a role in modulation of growth
and morphogenesis, and decreased levels in DPT induced PKD
results in aberrant growth of the kidney. This explanation is
consistent with our observations (unpublished) that TIN antigen
appears embryologically in association with developed tubular
basement membranes. On the other hand, the normal role of TIN
antigen and its role in PKD remain to be determined.
In PKD, progressive segmental expansion of renal tubules may
be due to aberration of one or more factors regulating tubular
morphogenesis. Tubular cells undergo programmed death (apop-
tosis) and regeneration; and TBM and interstitial stromal com-
ponents are in a state of dynamic metabolic turnover. Well-
regulated modulation of these processes is required for
maintenance of normal tubular morphology. The aberrant gene
product(s) in PKD is unknown; however, the defect(s) in the
mechanisms modulating tubular-matrix morphology could result
in altered cell-matrix interactions with changes in TBM-ECM
components and resultant tubular dysmorphogenesis.
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